2019 Bio International Convention
3-6 June 2019
Philadelphia, USA
CPhl Worldwide
5-7 November 2019
Frankfurt, Germany
Bio Europe
11-13 November 2019
Hamburg, Germany
Jefferies London Healthcare Conference
20-21 November 2019
London, UK
Please contact us if you are interested in meeting.
Code No: UK/CH/0319/0067k
Date of Preparation: March 2019
elmiron® for bladder pain syndrome not recommended in initial assessment by NICE
by Ab UkConsilient Health is extremely disappointed that the initial recommendation from the National Institute for Health and Care Excellence (NICE), detailed in its appraisal consultation document (ACD) released today, is negative for elmiron® (pentosan polysulfate sodium). elmiron is the only licensed oral medication for bladder pain syndrome (BPS) with glomerulations or Hunner’s lesions (referred to as interstitial […]
Angelini Farmaceutica to distribute Benferol® in Spain
by Ab UkConsilient Health is pleased to announce that we have signed a long term, exclusive agreement with Angelini Farmaceutica S.A for them to launch and distribute Benferol® in the Spanish market. “Spain is an extremely important territory for Benferol® “, commented Executive Vice Chairman Luke Crosbie. “We are delighted to be partnering with a company as […]
Agreement signed for elmiron® with bene-Arzneimittel GmbH
by Rebecca TaylorConsilient Health are pleased to announce the signing of a long-term, exclusive distribution agreement with bene-Arzneimittel GmbH, a Munich-based pharmaceutical company, to distribute elmiron® in the UK. The UK deal was signed on 8th May 2018 and, further to that, a distribution agreement was signed on 26th November 2018 for Ireland for elmiron®. elmiron® allows […]
Consilient Health welcomes Non-Executive Director, Harald F. Stock PhD
by Ab UkConsilient Health is pleased to announce the appointment of Harald F. Stock PhD as Non-Executive Director of the Company. Harald has worked in the industry for over 22 years. His extensive experience working with pharmaceuticals, diagnostics and medical devices compliments Consilient Health’s capabilities in a broad range of therapeutic areas. Harald has worked within a […]
Consilient Health Limited Announces Board Changes
by Rebecca TaylorConsilient Health is pleased to announce the appointment of Mr John Dixon as Non-Executive Director of the Company. John joined the pharmaceutical industry in 1974 and, from 1982, remained with Boehringer Ingelheim. During that time John is well known for heading up the Global Respiratory Marketing function and for launching BI’s first ever blockbuster “Spiriva” […]